Verification of Death by Neurologic Criteria: A Survey of 12 Organ Procurement Organizations Across the United States.

Brain death Death by neurologic criteria Organ donation Organ procurement organization

Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
15 May 2024
Historique:
received: 02 02 2024
accepted: 10 04 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 15 5 2024
Statut: aheadofprint

Résumé

The Center for Medicare and Medicaid Services requires Organ Procurement Organizations (OPOs) to verify and document that any potential organ donor has been pronounced dead per applicable legal requirements of local, state, and federal laws. However, OPO practices regarding death by neurologic criteria (DNC) verification are not standardized, and little is known about their DNC verification processes. This study aimed to explore OPO practices regarding DNC verification in the United States. An electronic survey was sent to all 57 OPOs in the United States from June to September 2023 to assess verification of policies and practices versus guidelines, concerns about policies and practices, processes to address concerns about DNC determination, and communication practices. Representatives from 12 OPOs across six US regions completed the entire survey; 8 of 12 reported serving > 50 referral hospitals. Most respondents (11 of 12) reported comparing their referral hospital's DNC policies with the 2010 American Academy of Neurology Practice Parameter and/or other (4 of 12) guidelines. Additionally, most (10 of 12) reported independently reviewing and verifying each DNC determination. Nearly half (5 of 12) reported concerns about guideline-discordant hospital policies, and only 3 of 12 thought all referral hospitals followed the 2010 American Academy of Neurology Practice Parameter in practice. Moreover, 9 of 12 reported concerns about clinician knowledge surrounding DNC determination, and most (10 of 12) reported having received referrals for patients whose DNC declaration was ultimately reversed. All reported experiences in which their OPO requested additional assessments (11 of 12 clinical evaluation, 10 of 12 ancillary testing, 9 of 12 apnea testing) because of concerns about DNC determination validity. Accurate DNC determination is important to maintain public trust. Nearly all OPO respondents reported a process to verify hospital DNC policies and practices with medical society guidelines. Many reported concerns about clinician knowledge surrounding DNC determination and guideline-discordant policies and practices. Educational and regulatory advocacy efforts are needed to facilitate systematic implementation of guideline-concordant practices across the country.

Sections du résumé

BACKGROUND BACKGROUND
The Center for Medicare and Medicaid Services requires Organ Procurement Organizations (OPOs) to verify and document that any potential organ donor has been pronounced dead per applicable legal requirements of local, state, and federal laws. However, OPO practices regarding death by neurologic criteria (DNC) verification are not standardized, and little is known about their DNC verification processes. This study aimed to explore OPO practices regarding DNC verification in the United States.
METHODS METHODS
An electronic survey was sent to all 57 OPOs in the United States from June to September 2023 to assess verification of policies and practices versus guidelines, concerns about policies and practices, processes to address concerns about DNC determination, and communication practices.
RESULTS RESULTS
Representatives from 12 OPOs across six US regions completed the entire survey; 8 of 12 reported serving > 50 referral hospitals. Most respondents (11 of 12) reported comparing their referral hospital's DNC policies with the 2010 American Academy of Neurology Practice Parameter and/or other (4 of 12) guidelines. Additionally, most (10 of 12) reported independently reviewing and verifying each DNC determination. Nearly half (5 of 12) reported concerns about guideline-discordant hospital policies, and only 3 of 12 thought all referral hospitals followed the 2010 American Academy of Neurology Practice Parameter in practice. Moreover, 9 of 12 reported concerns about clinician knowledge surrounding DNC determination, and most (10 of 12) reported having received referrals for patients whose DNC declaration was ultimately reversed. All reported experiences in which their OPO requested additional assessments (11 of 12 clinical evaluation, 10 of 12 ancillary testing, 9 of 12 apnea testing) because of concerns about DNC determination validity.
CONCLUSIONS CONCLUSIONS
Accurate DNC determination is important to maintain public trust. Nearly all OPO respondents reported a process to verify hospital DNC policies and practices with medical society guidelines. Many reported concerns about clinician knowledge surrounding DNC determination and guideline-discordant policies and practices. Educational and regulatory advocacy efforts are needed to facilitate systematic implementation of guideline-concordant practices across the country.

Identifiants

pubmed: 38750393
doi: 10.1007/s12028-024-02001-6
pii: 10.1007/s12028-024-02001-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.

Références

Lewis A, Bernat JL, Blosser S, Bonnie RJ, Epstein LG, Hutchins J, et al. An interdisciplinary response to contemporary concerns about brain death determination. Neurology. 2018;90(9):423–6.
doi: 10.1212/WNL.0000000000005033 pubmed: 29386276
Truog RD, Robinson WM. Role of brain death and the dead-donor rule in the ethics of organ transplantation. Crit Care Med. 2003;31(9):2391–6.
doi: 10.1097/01.CCM.0000090869.19410.3C pubmed: 14501972
National Data. Organ procurement & transplant network. Accessed January 24, 2024. optn.transplant.hrsa.gov/data/view-data-reports/national-data/
New organ procurement organization (OPO) survey protocol and guidance revisions in appendix Y of the State Operations Manual (SOM). US Department of Health and Human Services. July 8, 2020. Accessed January 24, 2024. hhs.gov/guidance/document/new-organ-procurement-organization-opo-survey-protocol-and-guidance-revisions-appendix-y
Lele AV, Wahlster S, Bost I, Adorno D, Wells C, O’Connor K, et al. a review of practices around determination of death by neurologic criteria by an organ procurement organization in the WAMI region. Neurol Clin Pract. 2022;12(5):336–43.
doi: 10.1212/CPJ.0000000000200077 pubmed: 36380895 pmcid: 9647811
Wijdicks EF, Varelas PN, Gronseth GS, Greer DM; American Academy of Neurology. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911–8.
Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of brain death/death by neurologic criteria: the World Brain Death Project. JAMA. 2020;324(11):1078–97.
doi: 10.1001/jama.2020.11586 pubmed: 32761206
Nakagawa TA, Ashwal S, Mathur M, Mysore MR, Bruce D, Conway EE Jr, et al.; Society of Critical Care Medicine; Section on Critical Care and Section on Neurology of the American Academy of Pediatrics; Child Neurology Society. Guidelines for the determination of brain death in infants and children: an update of the 1987 Task Force recommendations. Crit Care Med. 2011;39(9):2139–55.
Greer DM, Kirschen MP, Lewis A, Gronseth GS, Rae-Grant A, Ashwal S, et al. Pediatric and adult brain death/death by neurologic criteria consensus guideline [published correction appears in Neurology. 2024 Feb 13;102(3):e208108]. Neurology. 2023;101(24):1112–32.
Wahlster S, Wijdicks EF, Patel PV, Greer DM, Hemphill JC 3rd, Carone M, et al. Brain death declaration: practices and perceptions worldwide. Neurology. 2015;84(18):1870–9.
doi: 10.1212/WNL.0000000000001540 pubmed: 25854866 pmcid: 4433464
Lewis A, Adams N, Varelas P, Greer D, Caplan A. Organ support after death by neurologic criteria: results of a survey of US neurologists. Neurology. 2016;87(8):827–34.
doi: 10.1212/WNL.0000000000003008 pubmed: 27449064
Lewis A, Adams N, Chopra A, Kirschen MP. organ support after death by neurologic criteria in pediatric patients. Crit Care Med. 2017;45(9):e916–24.
doi: 10.1097/CCM.0000000000002452 pubmed: 28471816
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
doi: 10.1016/j.jbi.2008.08.010 pubmed: 18929686
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al.; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Organ Procurement Organization Services. Association of organ procurement organizations. 2022. Accessed November 7, 2023. https://aopo.org/opo-services/
Lewis A. Prevention of false-positive determinations of death by neurologic criteria requires education, regulation, and revision of hospital policies. Neurol Clin Pract. 2022;12(5):334–5.
doi: 10.1212/CPJ.0000000000200090 pubmed: 36380897 pmcid: 9647799
Greer DM, Wang HH, Robinson JD, Varelas PN, Henderson GV, Wijdicks EF. Variability of brain death policies in the United States. JAMA Neurol. 2016;73(2):213–8.
doi: 10.1001/jamaneurol.2015.3943 pubmed: 26719912
Francoeur C, Weiss MJ, MacDonald JM, Press C, Greer DM, Berg RA, et al. Variability in pediatric brain death determination protocols in the United States. Neurology. 2021;97(3):e310–9.
doi: 10.1212/WNL.0000000000012225 pubmed: 34050004
Braksick SA, Robinson CP, Gronseth GS, Hocker S, Wijdicks EF, Rabinstein AA. Variability in reported physician practices for brain death determination. Neurology. 2019;92(9):e888–94.
doi: 10.1212/WNL.0000000000007009 pubmed: 30804063 pmcid: 7987866
MacDougall BJ, Robinson JD, Kappus L, Sudikoff SN, Greer DM. Simulation-based training in brain death determination. Neurocrit Care. 2014;21(3):383–91.
doi: 10.1007/s12028-014-9975-x pubmed: 24692109
Rubin MA, Kirschen MP, Lewis A. The neurocritical care brain death determination course: purpose, design, and early findings. Neurocrit Care. 2021;35(3):913–5.
doi: 10.1007/s12028-021-01275-4 pubmed: 34131839

Auteurs

Kasra Sarhadi (K)

University of Washington, Seattle, WA, USA. ksarhadi@uw.edu.

Kristopher A Hendershot (KA)

University of Washington, Seattle, WA, USA.

Natalie Smith (N)

University of Washington, Seattle, WA, USA.

Michael Souter (M)

University of Washington, Seattle, WA, USA.

Claire Creutzfeldt (C)

University of Washington, Seattle, WA, USA.

Abhijit Lele (A)

University of Washington, Seattle, WA, USA.

Carolina Maciel (C)

University of Florida, Gainesville, FL, USA.

Katharina Busl (K)

University of Florida, Gainesville, FL, USA.

Julius Balogh (J)

University of Arkansas for Medical Sciences, Little Rock, AR, USA.

David Greer (D)

Boston University School of Medicine, Boston, MA, USA.

Ariane Lewis (A)

NYU Langone Medical Center, New York, NY, USA.

Sarah Wahlster (S)

University of Washington, Seattle, WA, USA.

Classifications MeSH